Readings Newsletter
Become a Readings Member to make your shopping experience even easier.
Sign in or sign up for free!
You’re not far away from qualifying for FREE standard shipping within Australia
You’ve qualified for FREE standard shipping within Australia
The cart is loading…
Multiple Sclerosis - Pathways, Diagnosis and Therapeutic Targets offers a comprehensive and up-to-date overview of the complex mechanisms underlying multiple sclerosis (MS), from molecular pathways and immune system dysregulation to emerging diagnostic tools and novel therapeutic strategies. This book is an essential resource for clinicians, researchers, and students seeking to understand the pathogenesis of MS, the latest in MS biomarker research, and current advances in immunomodulatory and neuroprotective treatments. Key topics include neuroinflammation, blood-brain barrier dysfunction, and disease-modifying therapies, with a special focus on personalized medicine and future drug development. With contributions from leading experts in neurology and neuroimmunology, this volume combines scientific depth with clinical relevance. Its unique strength lies in bridging the gap between basic science and clinical application, making it a valuable tool for translational research. Whether exploring MS diagnostic criteria, MRI advances, or therapeutic targets such as B cells and cytokine pathways, this book equips readers with critical insights into MS pathophysiology and management.
$9.00 standard shipping within Australia
FREE standard shipping within Australia for orders over $100.00
Express & International shipping calculated at checkout
Multiple Sclerosis - Pathways, Diagnosis and Therapeutic Targets offers a comprehensive and up-to-date overview of the complex mechanisms underlying multiple sclerosis (MS), from molecular pathways and immune system dysregulation to emerging diagnostic tools and novel therapeutic strategies. This book is an essential resource for clinicians, researchers, and students seeking to understand the pathogenesis of MS, the latest in MS biomarker research, and current advances in immunomodulatory and neuroprotective treatments. Key topics include neuroinflammation, blood-brain barrier dysfunction, and disease-modifying therapies, with a special focus on personalized medicine and future drug development. With contributions from leading experts in neurology and neuroimmunology, this volume combines scientific depth with clinical relevance. Its unique strength lies in bridging the gap between basic science and clinical application, making it a valuable tool for translational research. Whether exploring MS diagnostic criteria, MRI advances, or therapeutic targets such as B cells and cytokine pathways, this book equips readers with critical insights into MS pathophysiology and management.